Clinical Trial Update: Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial. [Phase 2]

View source ↗

Summary

Phase IIb clinical trial evaluating Lomecel-B injections in patients with Hypoplastic Left Heart Syndrome is currently active but not recruiting. The sponsor is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoplastic Left Heart Syndrome

Drugs mentioned

• Lomecel-B (bone marrow-derived mesenchymal stromal cells)

Snippet

Sponsor: Longeveron Inc. | Conditions: Hypoplastic Left Heart Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING